Molly Henderson

Molly Henderson

Director of Finance/CFO at PHATHOM PHARMACEUTICALS, INC.

Net worth: 884 283 $ as of 29/04/2024

54 year
Health Technology
Commercial Services
Producer Manufacturing

Molly Henderson active positions

CompaniesPositionStartEnd
PHATHOM PHARMACEUTICALS, INC. Comptroller/Controller/Auditor 04/04/2022 -
Director of Finance/CFO 04/04/2022 -

Career history of Molly Henderson

Former positions of Molly Henderson

CompaniesPositionStartEnd
CALLIDITAS THERAPEUTICS AB Director/Board Member 24/06/2020 29/05/2023
Independent Dir/Board Member - 29/05/2023
UROGEN PHARMA LTD. Comptroller/Controller/Auditor 30/09/2020 24/03/2022
Director of Finance/CFO 30/09/2020 24/03/2022
AYALA PHARMACEUTICALS, INC. Director of Finance/CFO 05/06/2018 24/09/2020
IOVANCE BIOTHERAPEUTICS, INC. Director of Finance/CFO 07/06/2015 31/07/2016
Investor Relations Contact 07/06/2015 31/07/2016
VIRTUALSCOPICS INC Director of Finance/CFO 30/04/2003 30/08/2013
Corporate Secretary 01/11/2009 30/08/2013
ULTRALIFE CORPORATION Comptroller/Controller/Auditor 31/07/2000 31/07/2002
Comptroller/Controller/Auditor - -

Training of Molly Henderson

State University of New York at Buffalo Graduate Degree

Statistics

International

United States 8
Switzerland 2
Sweden 2

Operational

Director of Finance/CFO 5
Comptroller/Controller/Auditor 4
Corporate Secretary 1

Sectoral

Health Technology 6
Commercial Services 3
Producer Manufacturing 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies5
ULTRALIFE CORPORATION

Producer Manufacturing

IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

CALLIDITAS THERAPEUTICS AB

Health Technology

UROGEN PHARMA LTD.

Health Technology

PHATHOM PHARMACEUTICALS, INC.

Health Technology

Private companies3

Commercial Services

Commercial Services

Health Technology

See company connections